Publicado
Marihuana: ¿la mata que mata o la mata que cura?
Palabras clave:
marihuana, medicinas ancestrales, cannabis, cannabidiol, Ley de Sustancias Controladas (es)Descargas
Referencias
Dean R.L., Bilsky E.J. & Negus S.S. (2009). Opiate Receptors and Antagonists: From Bench to Clinic. New York Humana Press. doi: 10.1007/978-1-59745-197-0_6
Meccariello, R. & Chianese, R. (2016). Cannabinoids in Health and Disease. InTechOpen. doi: 10.5772/61595
Antonelli T, Tomasini MC, Tattoli M, et al. (2005). Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring. Cereb Cortex N Y N 1991. 15(12):2013-2020. doi:10.1093/cercor/bhi076.
Verrico CD, Gu H, Peterson ML, Sampson AR, Lewis DA. (2014). Repeated Δ9- tetrahydrocannabinol exposure in adolescent monkeys: persistent effects selective for spatial working memory. Am J Psychiatry 171(4):416-425. doi:10.1176/appi.ajp.2013.13030335.
Rubino T, Realini N, Braida D, et al. (2009). Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood. Hippocampus 19(8):763-772. doi:10.1002/hipo.20554.
Gleason KA, Birnbaum SG, Shukla A, Ghose S. (2012). Susceptibility of the adolescent brain to cannabinoids: long-term hippocampal effects and relevance to schizophrenia. Transl Psychiatry 2:e199. doi:10.1038/tp.2012.122.
Quinn HR, Matsumoto I, Callaghan PD, et al. (2008). Adolescent rats find repeated Delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol 33(5):1113-1126. doi:10.1038/sj.npp.1301475.
Barak, M., Ben-Shlomo, I., & Katz, Y. (2001). Changes in Effective and Lethal Doses of Intravenous Anesthetics and Lidocaine When Used in Combination in Mice. Journal of Basic & Clinical Physiology & Pharmacology, 12(4), 315–323.
Kogan, N. M., & Mechoulam, R. (2007). Cannabinoids in health and disease. Dialogues in Clinical Neuroscience, 9(4), 413–430. https://doi.org/10.1515/jbcpp-2016-0045
Pérez Pérez, H., Rubio, C., Martín, R. E., & Hardisson, A. (2003). Toxicología de las drogas de síntesis. Rev. Toxicol., 20, 182–186.
Barak, M., Ben-Shlomo, I., & Katz, Y. (2001). Changes in Effective and Lethal Doses of Intravenous Anesthetics and Lidocaine When Used in Combination in Mice. Journal of Basic & Clinical Physiology & Pharmacology, 12(4), 315–323.
Kogan, N. M., & Mechoulam, R. (2007). Cannabinoids in health and disease. Dialogues in Clinical Neuroscience, 9(4), 413–430. https://doi.org/10.1515/jbcpp-2016-0045
Pérez Pérez, H., Rubio, C., Martín, R. E., & Hardisson, A. (2003). Toxicología de las drogas de síntesis. Rev. Toxicol., 20, 182–186.
Cómo citar
APA
ACM
ACS
ABNT
Chicago
Harvard
IEEE
MLA
Turabian
Vancouver
Descargar cita
Visitas a la página del resumen del artículo
Descargas
Licencia
Derechos de autor 2017 Morfolia
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Derechos de autor reservados